If you liked this article you might like

There May Be a Buying Opportunity When Pfizer Shares Hit This Important Level
Pfizer Continues to Plunge -- Get Ready to Buy on the Dip
Eli Lilly Acquires CoLucid Pharma, Adds Migraine Drug to Pipeline
Why Bristol-Myers Squibb May Be a Merger Target Soon